about
The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of AmericaInpatient capacity at children's hospitals during pandemic (H1N1) 2009 outbreak, United StatesChildren's hospitals do not acutely respond to high occupancy.Differential case ascertainment in clinical registry versus administrative data and impact on outcomes assessment for pediatric cardiac operationsAdministrative data: expanding the infrastructure for pediatric research.Readmissions among children previously hospitalized with pneumonia.Streptococcus pneumoniae-associated hemolytic uremic syndrome among children in North America.Costs of treating children with complicated pneumonia: a comparison of primary video-assisted thoracoscopic surgery and chest tube placement.An epidemiologic review of enteropathogens in Gaborone, Botswana: shifting patterns of resistance in an HIV endemic regionIncreasing incidence of gram-negative rod bacteremia in a newborn intensive care unit.Enhancing Comparative Effectiveness Research With Automated Pediatric Pneumonia Detection in a Multi-Institutional Clinical Repository: A PHIS+ Pilot StudyHerpes simplex virus testing and hospital length of stay in neonates and young infantsInfection due to Moraxella osloensis: case report and review of the literature.National trends in psychotropic medication use in young children: 1994-2009Epidemiology of methicillin-resistant Staphylococcus aureus bacteremia in Gaborone, BotswanaNational hospitalization trends for pediatric pneumonia and associated complicationsDecline in varicella-related ambulatory visits and hospitalizations in the United States since routine immunization against varicella.Admission chest radiographs predict illness severity for children hospitalized with pneumoniaAntibiotic prescribing in ambulatory pediatrics in the United States.Group C streptococcal meningitis: case report and review of the literature.Variation in the management of infants hospitalized for bronchiolitis persists after the 2006 American Academy of Pediatrics bronchiolitis guidelines.Age-specific reference values for cerebrospinal fluid protein concentration in neonates and young infants.Prevalence and characteristics of antimicrobial stewardship programs at freestanding children's hospitals in the United States.Pediatric severe sepsis in U.S. children's hospitals.Adjunct corticosteroids in children hospitalized with community-acquired pneumoniaCharacteristics associated with pediatric inpatient death.Defining cerebrospinal fluid white blood cell count reference values in neonates and young infants.Cecal volvulus in childhood.Blood cultures in the emergency department evaluation of childhood pneumoniaCSF opening pressure in children with optic nerve head edema.Comparative effectiveness of pleural drainage procedures for the treatment of complicated pneumonia in childhoodAddressing inpatient crowding by smoothing occupancy at children's hospitalsStatistical uncertainty of mortality rates and rankings for children's hospitals.Executive summary: the management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America.The child with aseptic meningitis.Cat scratch disease presenting as orbital abscess and osteomyelitisVariation in prevalence, diagnostic criteria, and initial management options for eosinophilic gastrointestinal diseases in the United States.Narrow vs broad-spectrum antimicrobial therapy for children hospitalized with pneumonia.Comparative effectiveness of empiric antibiotics for community-acquired pneumoniaVitamin D deficiency is associated with type 2 diabetes mellitus in HIV infection.
P50
Q22242904-7FADC974-27F9-4BA8-A874-D7326EDB9CC2Q30406695-F1E2750A-F772-48F4-BF12-F52C1D757580Q30432562-D17814E9-834E-41FE-8FFA-8AA398FDCD87Q30577033-63D5137E-4014-40A2-8591-AA2E82524D1CQ30579190-D7CB1F25-CC26-46E0-910C-FC703D9BE243Q30660625-0E520D52-4065-4C5C-8B14-BA371A1BDA58Q33396296-AA2BFC68-CFB1-4F3E-9E56-648207745297Q33556037-AB5705B1-FB67-4026-8D07-EC9F729BA11AQ33602940-7DF9E953-0638-4D05-BB4C-B0589D590AE1Q33706991-F6DEF00C-19F3-42CE-BF59-CD94BAB44176Q33736906-7E58273F-3990-4381-BC44-920C96511E05Q33788012-B2637B08-17AF-4155-BAFF-C0502761940CQ33808325-D24C7B84-F8A9-4A76-9BBD-D65DD088772CQ33819699-FBF79FE0-E568-49C6-83DD-ACED0335F095Q33999981-91F07094-80E6-4C27-A6F4-A5D64768F732Q34039927-4A9729E6-6426-4AC8-8E90-06D90A88DF13Q34074644-2F2CAE26-0878-40FC-BF4E-6349815D3F7AQ34135388-A1EE37F8-039F-429E-9855-98279BD879D6Q34230740-D654D1A0-8889-43C3-BDFD-E371A251CAB3Q34238470-64B17F57-8AAE-4D32-A4EA-2395A398E87BQ34254849-83856929-BD4D-4524-8552-A3658F104FD0Q34300180-E90518FE-8837-449D-A4A1-ADDC2F56E3DFQ34403874-7517F691-FF18-4816-99ED-D195ED0C0D58Q34458855-F0166C46-FA1B-479B-80B1-547B1F63501AQ34512999-C8147E4D-4334-46AC-B983-874792031920Q34551382-57E838F9-9436-43E1-A5EB-A0C4B70D1157Q34552865-3E85D103-A667-4112-A098-E3724DCA383EQ34789541-AED85A26-4846-4827-8548-F1B243982C8BQ34990250-C90880DB-F84E-41CD-BBF5-4D3E4C7D836DQ34999224-D2A582EE-21B0-478C-BE88-C9764A23A539Q35038706-6993EA5E-AEA9-42EE-A72E-662F6C8C6273Q35184744-8798F411-66C6-4B05-8F35-162904244ABAQ35240537-5B97F0DC-33F0-4FB4-BBF5-FCC60E5C68ECQ35452403-5A56AEF8-8182-4493-AF15-E4591B981097Q35547616-0DE88FBA-9BFD-4DD5-9700-5A9A4DF57926Q35638808-3E77CBAA-7B6C-4E64-859B-57ADDB8E410EQ35670453-2D0889BB-D5E1-4A48-B870-FF83F433AD3EQ35932517-A49E8B67-98B5-4F9C-9A66-A2BC8F69C9E1Q35948750-37E9ED00-90E2-45B0-AE3A-1AE7007550D4Q36006301-64D23DA6-7160-4855-9734-FAB85E6702D0
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Samir S. Shah
@ast
Samir S. Shah
@en
Samir S. Shah
@es
Samir S. Shah
@sl
type
label
Samir S. Shah
@ast
Samir S. Shah
@en
Samir S. Shah
@es
Samir S. Shah
@sl
prefLabel
Samir S. Shah
@ast
Samir S. Shah
@en
Samir S. Shah
@es
Samir S. Shah
@sl
P1053
B-2661-2015
P106
P1153
7403888647
P21
P31
P3829
P496
0000-0001-7902-7000